Hints and tips:
Related Special Reports
...This article has been amended to clarify details of the proposed drug trial by the NHS and Novartis...
...“There’s a backlash against corporations using commercial power to advance political and social agendas,” he said....
...Merck, BMS, J&J, Novartis and some trade groups have launched a legal broadside against them, filing lawsuits in several different courts across the US....
...Haleon was a joint venture between GSK and Pfizer that included consumer brands acquired from Novartis....
...In 2020, when pharmaceutical manufacturers Roche and Novartis were fined €444mn for allegedly pushing their jointly marketed eye medicine Lucentis over a cheaper alternative, Thill-Tayara successfully argued...
...The Swiss pharmaceutical firm Novartis has just dropped plans to run a large clinical trial in the UK, which would have involved 40,000 patients testing a cholesterol drug....
...Psilocybin was first clinically manufactured in 1959 by Sandoz, now part of Novartis, but the company had never commercialised it....
...Novartis said it did not think the decline in sales was linked to reports of deaths of two children who had taken the drug....
...At Swiss pharmaceutical company Novartis, suppliers — which range from producers of ingredients, materials and finished goods to transport and real estate businesses — generate just over 90 per cent of its...
...In the canton of Basel-Stadt for example, home to 201,000 residents as well as the pharmaceutical companies Roche and Novartis, 20 per cent of government revenues — about CHF600m annually — come from corporation...
...“I think that is how our corporations need to be.”...
...When Shannon Thyme Klinger left the top legal job at Swiss pharmaceutical group Novartis to join US biotech Moderna this month, she was motivated by a deep sense of purpose — professional and personal....
...The deal settles civil allegations against its US arm, Novartis Pharmaceuticals Corporation, and is the company’s third big resolution with US authorities in recent months....
...Takeda has secured a number of borrowing facilities including a $30.9bn bridge loan led by JPMorgan Chase, Sumitomo Mitsui Banking Corporation and MUFG Bank....
...Idexx said in October that the animal health market had experienced a “V-shaped recovery”....
...The Big Three are on course to control 40 per cent of the votes in American corporations in a couple of decades....
...Lanny Davis, an attorney for Mr Cohen, did not immediately return a request for comment....
...Large, venerable corporations can struggle to see what lies ahead for their industry. Consider Novartis....
...The pharmaceuticals industry was a big beneficiary of the president's recent tax changes. Here’s our guide to drug pricing....
...The lawsuit is a stark example of the use of non-competes by large corporations, even against low-level hourly wage workers....
...As the pace of discoveries has quickened in recent years, it has turned into a kind of rock festival for the pharmaceutical industry....
...The company had just completed its first big live demonstration for a pharmaceutical company....
...Until a pharmaceuticals group develops a “disease-modifying” medicine, patients must make do with a handful of drugs that only slightly ameliorate the ravages of Alzheimer’s disease — which accounts for...
...Last year he advised Swiss pharmaceutical group Novartis on its purchase of AveXis, structured General Electric’s $11bn locomotive combination with Wabtec, and offered advice on the $6.4bn sale of ABB’s...
...and Takeda Pharmaceuticals....
International Edition